Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Endo

Showing results (371-380 of 395) with videos related to

Pageof 40
Sort By:
British Journal of Cancer|April 28, 2022
HIF-1α stimulates the progression of oesophageal squamous cell carcinoma by activating the Wnt/β-catenin signalling pathwayKang Tang, Takeshi Toyozumi, Kentaro Murakami, et al.
JTCVS Open|September 19, 2024
Immunohistochemistry of p53 surrogates <i>TP53</i> mutation as an accurate predictor for early-relapse of surgically resected stage I-III lung adenocarcinomaYasuyuki Kurihara, Takayuki Honda, Akira Takemoto, et al.
Journal of Medicinal Chemistry|October 5, 2017
Synthesis of Potent and Selective Inhibitors of Aldo-Keto Reductase 1B10 and Their Efficacy against Proliferation, Metastasis, and Cisplatin Resistance of Lung Cancer CellsSatoshi Endo, Shuang Xia, Miho Suyama, et al.
Journal of Medicinal Chemistry|January 12, 2018
Correction to Synthesis of Potent and Selective Inhibitors of Aldo-Keto Reductase 1B10 and Their Efficacy against Proliferation, Metastasis, and Cisplatin Resistance of Lung Cancer CellsSatoshi Endo, Shuang Xia, Miho Suyama, et al.
Journal of Medicinal Chemistry|August 28, 2020
Development of Novel AKR1C3 Inhibitors as New Potential Treatment for Castration-Resistant Prostate CancerSatoshi Endo, Hiroaki Oguri, Jin Segawa, et al.
Bioorganic & Medicinal Chemistry|August 21, 2013
Design, synthesis, and structure-activity relationships of dihydrofuran-2-one and dihydropyrrol-2-one derivatives as novel benzoxazin-3-one-based mineralocorticoid receptor antagonistsTomoaki Hasui, Taiichi Ohra, Norio Ohyabu, et al.
Environmental Science & Technology|May 19, 2010
More of EPA's SPARC online calculator--the need for high-quality predictions of chemical propertiesHans Peter H Arp, Steven T J Droge, Satoshi Endo, et al.
Bioorganic & Medicinal Chemistry Letters|September 28, 2011
Design, synthesis, and structure-activity relationships of spirolactones bearing 2-ureidobenzothiophene as acetyl-CoA carboxylases inhibitorsTohru Yamashita, Makoto Kamata, Satoshi Endo, et al.
ERJ Open Research|February 26, 2025
A strong association between TTF-1 expression and interstitial lung disease in predicting the efficacy of PD-1 inhibitor for nonsquamous NSCLC patientsMasaru Ito, Takayuki Honda, Iichiroh Onishi, et al.
Internal Medicine (Tokyo, Japan)|August 9, 2023
Pulmonary Artery Aneurysm in a Patient with Nontuberculous Mycobacteria InfectionSoichi Maruyama, Haruhiko Furusawa, Satoshi Endo, et al.
Pageof 40

Showing results (371-380 of 395) with videos related to

Sort By:
Pageof 40
British Journal of Cancer|April 28, 2022
HIF-1α stimulates the progression of oesophageal squamous cell carcinoma by activating the Wnt/β-catenin signalling pathwayKang Tang, Takeshi Toyozumi, Kentaro Murakami, et al.
JTCVS Open|September 19, 2024
Immunohistochemistry of p53 surrogates <i>TP53</i> mutation as an accurate predictor for early-relapse of surgically resected stage I-III lung adenocarcinomaYasuyuki Kurihara, Takayuki Honda, Akira Takemoto, et al.
Journal of Medicinal Chemistry|October 5, 2017
Synthesis of Potent and Selective Inhibitors of Aldo-Keto Reductase 1B10 and Their Efficacy against Proliferation, Metastasis, and Cisplatin Resistance of Lung Cancer CellsSatoshi Endo, Shuang Xia, Miho Suyama, et al.
Journal of Medicinal Chemistry|January 12, 2018
Correction to Synthesis of Potent and Selective Inhibitors of Aldo-Keto Reductase 1B10 and Their Efficacy against Proliferation, Metastasis, and Cisplatin Resistance of Lung Cancer CellsSatoshi Endo, Shuang Xia, Miho Suyama, et al.
Journal of Medicinal Chemistry|August 28, 2020
Development of Novel AKR1C3 Inhibitors as New Potential Treatment for Castration-Resistant Prostate CancerSatoshi Endo, Hiroaki Oguri, Jin Segawa, et al.
Bioorganic & Medicinal Chemistry|August 21, 2013
Design, synthesis, and structure-activity relationships of dihydrofuran-2-one and dihydropyrrol-2-one derivatives as novel benzoxazin-3-one-based mineralocorticoid receptor antagonistsTomoaki Hasui, Taiichi Ohra, Norio Ohyabu, et al.
Environmental Science & Technology|May 19, 2010
More of EPA's SPARC online calculator--the need for high-quality predictions of chemical propertiesHans Peter H Arp, Steven T J Droge, Satoshi Endo, et al.
Bioorganic & Medicinal Chemistry Letters|September 28, 2011
Design, synthesis, and structure-activity relationships of spirolactones bearing 2-ureidobenzothiophene as acetyl-CoA carboxylases inhibitorsTohru Yamashita, Makoto Kamata, Satoshi Endo, et al.
ERJ Open Research|February 26, 2025
A strong association between TTF-1 expression and interstitial lung disease in predicting the efficacy of PD-1 inhibitor for nonsquamous NSCLC patientsMasaru Ito, Takayuki Honda, Iichiroh Onishi, et al.
Internal Medicine (Tokyo, Japan)|August 9, 2023
Pulmonary Artery Aneurysm in a Patient with Nontuberculous Mycobacteria InfectionSoichi Maruyama, Haruhiko Furusawa, Satoshi Endo, et al.
Pageof 40